FULC

FULC R&D Expense Growth

-11.49%Fiscal year

Period ending:

FULC FY R&D Growth (YoY)%
FULC FY R&D Growth (YoY)82.54%-21.82%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

FULC r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Fulcrum Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-11.4899%
-11.7199%
-6.4872%
10.1591%
18.0533%
35.9538%
72.4428%
36.1739%
0%

Compare r&d expense growth

All FULC financial metrics · FULC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.